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Reactions of β-bromo-β,γ-unsaturated pyrroline nitroxide aldehyde (1) or nitrile (4) or their diamagnetic
forms (5, 6) with 2-aminothiophenol or 2-mercaptobenzimidazole were evaluated. The reaction could be
reproduced more easily with the application of O-acetyl derivatives of nitroxides to generate 2-
substituted-benzothiazole, pyrrolo[3,4-b]benzo[1,5]tiazepine scaffolds with 2-aminothiophenol and
benzimidazo[2,1-b]pyrrolo[3,4-e]-[1,3]thiazine scaffold with 2-mercaptobenzimidazole.
J. Heterocyclic Chem., 00, 00 (2017).
INTRODUCTION
Extensive studies of stable nitroxide free radicals have
established the value of these unique compounds in
applications such as spin labels [1], co-oxidants [2],
building blocks for magnetic materials [3], synthesis of
paramagnetic biomolecules [4], and mediators of
polymerization [5]. These diverse applications were
possible after M.B. Neiman and E.G. Rozantsev, and
their group expanded the synthesis of nitroxide free
radicals into a broad range of compounds [6],
recognizing the limits of functionalization of TEMPO or
4-OXOTEMPO (Fig.F1 1).
To access further transformable stable nitroxide free
radical building blocks, our laboratory started the
synthesis of carbocycle and heterocycle condensed
nitroxide free radicals, which offer many possible
synthetic amendments. In these previous works, we
synthesized thiophene [7], selenophene [8], pyridine [9],
pyrrole [9,10], coumarin [11], phenanthrene [11], and
polyheterocycles [12] condensed stable nitroxide free
radicals. We reported the synthesis of 1,4-thiazepine
derivative 2 [7] and 2-thienylbenzimidazole derivative
3 [13] by treatment of 4-bromo-3-formyl-2,2,5,5-
tetramethyl-2,5-dihydro-1H-pyrrol-1-yloxyl radical 1
with cysteamine and 2-mercaptomethylbenzimidazole,
respectively (Fig. F22). However, reactions of 1 with 2-
aminothiophenol resulted in the formation of a mixture
of compounds.
In this article, we report the results of some reactions of
β-bromo-β,γ-unsaturated pyrroline nitroxide aldehyde or
nitrile with aromatic N-binucleophiles and S-binucleophiles
© 2017 Wiley Periodicals, Inc.
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to elucidate their unusual performance in reactions and to
ﬁnd a pathway to synthesize the series of paramagnetically
modiﬁed 1,5-benzothiazepine scaffolds, whose biological
importance is well reported in the literature [14–18].
RESULTS AND DISCUSSION
Based on previous reports [19], our hypothesis was that
nitroxides oxidize the aromatic thiols to the corresponding
disulﬁdes causing a nonreproducible reaction as in the case
of compound 1 and 2-aminothiophenol.
We proposed that a diamagnetic derivative of aldehyde 1
and nitrile 4 should be used in these reactions in such
forms, which prevent the oxidation of aromatic thiols,
because the formed aromatic disulﬁdes cannot react
further as S-nucleophiles. Therefore, compounds 1 and 4
were ﬁrst converted to the O-acetyl derivatives 5 and 6
by a previously reported methodology [20], through the
reduction to the corresponding hydroxylamine with
ascorbic acid, followed by treatment with acetyl chloride
in the presence of Et3N in chloroform (SchemeS1 1).
Heating the 1:1 mixture of 2-aminothiophenol and
compound 5 in the absence of a base in dimethyl
sulfoxide in a (4 + 1) cyclocondensation generated
2-substituted benzothiazole. For more convenient
isolation of compound 7, the crude product was
deacetylated with NaOMe in MeOH and oxidized with
0.1 equiv activated MnO2 with bubbling through O2 gas
(SchemeS2 2). The (4 + 1) cyclocondensation was proven
by elemental analysis and mass spectral measurements of
the product, indicating the presence of bromine in
molecular ion at 351/353/355 (M+). The formation of
benzothiazole is an acid-catalyzed process [21,22]
initiated by the protonation of the imine with the
participation of the SH acidic center, hence generating a
nucleophilic thiolate and imine carbon more electrophilic
than β-carbon.
Reaction of compound 5 and 2-aminothiophenol in
acetonitrile in the presence of 1.1 equiv DBU
gave 1,1,3,3-tetramethyl-2,3-dihydro-1H-pyrrolo[3,4-b]
benzo[1,5]thiazepin-2-acetate 8 in an (4 + 3)
cyclocondensation reaction. In this case, we propose that
the bromine substitution with thiolate—generated in basic
conditions—in the ﬁrst stage be followed by the Schiff
base formation. We assume the nucleophilic substitution
of bromine atom to be the “push–pull” process with
addition of thiolate to β-carbon, followed by halogen
cleavage with C3–C4 double bond restoration.
Deacetylation of compound 8, as described earlier,
offered compound 9. Reduction of compound 9 with 1.2
equiv NaBH4 in EtOH gave secondary amine 10. This
reduction is proven by appearance of CH2 signal at
3.79 ppm in 1H NMR spectrum, and this type of
Figure 2. Reaction of aldehyde 1 with various N-binucleophiles and S-binucleophiles.
Scheme 1. Synthesis of diamagnetic O-acetyl derivatives of 1 and 6.
Figure 1. Structure of stable nitroxide free radicals TEMPO and 4-
OXOTEMPO.
Scheme 2. Reaction of compound 5 with 2-aminothiophenol in dimethyl
sulfoxide (DMSO) in the absence of base.
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transformation is well documented in the literature
[23] as well. Methylation of compound 10
with CH3I in acetonitrile in the presence of K2CO3
generated compound 1,1,3,3,9-pentamethyl-9,10-dihydro-
1H-pyrrolo[3,4-b]benzo[1,5]thiazepin-2-yloxyl radical 11.
Oxidation of compound 11 in aqueous (aq) MeOH with
H2O2 in the presence of Na2WO4 furnished sulfone 12
(SchemeS3 3).
Reaction of compound 6 with 2-aminothiophenol in
acetonitrile and 1.1 equiv DBU furnished adduct 13. The
presence of the nitrile band in infrared (IR) at 2210 cm1
indicated that no ring closure occurred, because the nitrile
group of compound 6 is a weaker electrophile than the
formyl group in compounds 1 and 5, the latter giving
ring closure smoothly with aromatic amines. The
thiazepine ring formation can be initiated by reﬂuxing
compound 13 in EtOH, saturated with HCl gas. Along
with the ring closure, deacetylation also occurred, and
hence, after basic work-up followed by oxidation with
MnO2/O2, we obtained 10-amino-1,1,3,3-tetramethyl-2,3-
dihydro-1H-pyrrolo[3,4-b]benzo[1,5]thiazepin-2-yloxyl
radical 14 (SchemeS4 4).
Reaction of compound 1 with 2-mercaptobenzimidazole
in acetonitrile in the presence of 2.1 equiv DBU
with heating provided 11-hydroxy-1,1,3,3-tetramethyl-
1,2,3,11-tetrahydro-benzimidazo[2,1-b]pyrrolo[3,4-e][1,3]
thiazin-2-yloxyl radical 15 in a (3 + 3) cyclocondensation
reaction, in an analogous reaction published earlier by
Hungarian researchers [24] (Scheme S55).
CONCLUSIONS
Reactions of β-bromo-β,γ-unsaturated pyrroline
nitroxide aldehyde (1) or nitrile (4) or their O-acetyl
derivatives (5, 6) with various N-binucleophiles and
S-binucleophiles depending on reaction partners or
absence/presence of a base gave structurally diversiﬁed
paramagnetic polycyclic compounds. We suggested
camouﬂaging of the nitroxide function in the presence of
aromatic thiols in most cases to avoid unwanted side
reactions. Although reactions of nitroxides have been
studied for several decades, there are still many
challenges (selectivity problems) that remain to be
solved. We believe that the reactions studied in this work
are extendable to the reactions of any β-halogen-α,β-
unsaturated aldehydes or nitriles, giving a straightforward
synthetic access to a number of interesting fused S-
containing and N-containing polyheterocycles.
Experimental. Melting points were determined using
Boetius micro melting Q1point apparatus and are
uncorrected. Elemental analyses (C, H, N, S) were
performed on Fisons EA 1110 CHNS elemental analyser;
bromine determination was carried out titrimetrically by
Schöniger’s method. Mass spectra were recorded on a
Thermoquest Automass Multi. 1H NMR and 13C NMR
spectra were recorded with Bruker Avance 3 Ascend 500
spectrometer. Chemical shifts are referenced to Me4Si.
The paramagnetic compound was reduced with 5 equiv
Scheme 3. Synthesis of paramagnetic benzo[1,5]thiazepine derivatives from aldehyde 5.
Scheme 4. Synthesis of paramagnetic benzo[1,5]thiazepine derivative 14 from nitrile 6.
Scheme 5. Reaction of aldehyde 1 with 2-mercaptobenzimidazole.
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hydrazobenzene or pentaﬂuorophenyl hydrazineQ2 /radical.
Measurements were run at 298 K probe temperature in
CDCl3 or CD3OD solution. Electron spin resonance
spectra were taken on Miniscope MS 200 in 104 M
CHCl3 solution, and all monoradicals gave triplet line
aN = 14.4 G. The IR spectra were taken with Bruker
Alpha FTIR instrument with ATR support (ZnSe plate).
Flash column chromatography was performed on Merck
Kieselgel 60 (0.040–0.063 mm). Qualitative thin-layer
chromatography (TLC) was carried out on commercially
available plates (20 × 20 × 0.02 cm) coated with
Merck Kieselgel GF254. Compounds 1 [25] and 4 [7]
were prepared according to published procedures, and
other reagents were purchased from Aldrich or Alfa
Aesar.
Synthesis of diamagnetic O-acetyl derivatives, general
procedure (5, 6). Into a two-necked ﬂask equipped with
magnetic stirrer, N2 inlet, and condenser, we placed the
MgSO4 drying agent (10 g) and Et3N (1.11 g,
11.0 mmol). In another round bottomed ﬂask with two
necks, we placed compound 1 or 4 dissolved in
dioxane/water (3:1) (32 mL). The mixture was stirred at
35–40°C under N2, and ascorbic acid (8.80 g,
50.0 mmol) was added in four to ﬁve portions. After the
solution became colorless or pale yellow, it was extracted
in CHCl3 (2 × 20 mL), and the colorless bottom organic
phases were sunk down into the MgSO4, Et3N-containing
ﬂask directly. Then, the mixture was cooled to 0°C, and
AcCl (863 mg, 11.0 mmol) was added dropwise. After
removing the cooling bath, the mixture was allowed to
stir at ambient temperature for 1 h under N2. After
quenching with MeOH (1 mL), the mixture was ﬁltered
on a glass frit, the ﬁltrate was evaporated, and the residue
was partitioned between brine (10 mL) and EtOAc
(25 mL). The organic phase was separated, dried
(MgSO4), ﬁltered, and evaporated to offer a colorless
thick oil, which was further puriﬁed by ﬂash column
chromatography (hexane/Et2O).
3-Bromo-4-formyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-
pyrrol-1-yl acetate (5). white crystal, 1.39 g (48%), mp
71–72°C; Rf: 0.43 (hexane/Et2O, 2:1); IR: 2937, 2845,
1768, 1676, 1603 cm1; 1H NMR (500 MHz, CDCl3): δ
1.35 (s, 3H), 1.38 (s, 3H), 1.41 (s, 6H), 2.15 (s, 3H),
9.82 (s, 1H); 13C NMR (125 MHz, CDCl3): δ 19.0,
21.8, 21.9, 27.2, 27.4, 70.8, 72.6, 139.1, 145.6, 170.5,
188.1; MS (70 eV): m/z 291/289 (M+, 14/14), 276/274
(76/76), 249/247 (61/61), 234/232 (98), 43 (100). Anal.
Calcd. for C11H16BrNO3: C, 45.53; H, 5.56; N, 4.83;
Br, 27.54. Found: C, 45.38; H, 5.52; N, 4.76; Br, 27.40.
3-Bromo-4-cyano-2,2,5,5-tetramethyl-2,5-dihydro-1H-
pyrrol-1-yl acetate (6). white crystalline solid, 1.40 g
(57%), mp 60–61°C; Rf: 0.38 (hexane/Et2O, 2:1); IR:
2982, 2932, 2866, 2225, 1770, 1680, 1623 cm1; 1H
NMR (500 MHz, CDCl3): δ 1.34 (s, 3H), 1.37 (s, 3H),
1.40 (s, 3H), 1.46 (s, 3H), 2.15 (s, 3H); 13C NMR
(125 MHz, CDCl3): δ 18.9, 22.6 (2C), 27.5, 27.9,
71.7, 73.9, 113.1, 119.3, 141.6, 169.8; MS (70 eV):
m/z 288/286 (M+, 3/3), 273/271 (7/7), 246/244 (20/
20), 229/221 (100), 150 (45), 43 (73). Anal. Calcd.
for C11H15BrN2O2: C, 46.01; H, 5.27; N, 9.76; Br,
27.83. Found: C, 46.06; H, 5.06; N, 9.94; Br, 27.60.
3-(Benzthiazo-2-yl)-4-bromo-2,2,5,5-tetramethyl-2,5-
dihydro-1H-pyrrol-1-yloxyl radical (7). A solution of
compound 5 (580 mg, 2.0 mmol) and 2-aminothiophenol
(250 mg, 2.0 mmol) in dimethyl sulfoxide (5 mL) was
heated at 90°C for 2 h. After cooling, the solvent was
evaporated off, the residue was dissolved in MeOH
(10 mL), and freshly made NaOMe solution was added
(5 mL MeOH +5 mg Na metal). After standing at room
temperature (RT) for 30 min, the solvent was evaporated
off, and the residue was partitioned between saturated aq
NH4Cl solution (10 mL) and CHCl3 (10 mL). The
organic phase was extracted with CHCl3 (10 mL) again,
and the combined organic phases were dried (MgSO4),
activated MnO2 (43 mg, 0.5 mmol) was added, and O2
was bubbled through for 10 min. The mixture was
ﬁltered, evaporated, and puriﬁed by ﬂash column
chromatography (hexane/Et2O) to give compound 7 as a
yellow solid, 183 mg (26%), mp 84–85°C; Rf: 0.67
(hexane/Et2O, 2:1); IR: 3059, 2976, 2929, 2863, 1683,
1610, 1558 cm1; 1H NMR (500 MHz,
CD3OD + C6F5N2H3): δ 1.36 (s, 6H), 1.55 (s, 6H),
7.66–8.17 (m, 4H); 13C NMR (125 MHz,
CD3OD + C6F5N2H3): δ 23.8 (2C), 24.0 (2C), 71.3, 71.9,
121.1, 122.8, 125.5, 126.1, 131.7, 134.3, 152.1, 160.24;
MS (70 eV): m/z 355/353/351 (M+, 1>, 10/10), 310/308/
306 (1>/13/13), 242 (100), 226 (20). Anal. Calcd. for
C15H16BrN2OS: C, 51.14; H, 4.58; N, 7.95; S, 9.10; Br,
22.68. Found: C, 51.32; H, 4.72; N, 8.04; S, 8.95; Br,
22.50.
1,1,3,3-Tetramethyl-2,3-dihydro-1H-pyrrolo-[3,4-b]benzo
[1,5]thiazepin-2-acetate (8). To a solution of compound 5
(1.45 g, 5.0 mmol) and 2-aminothiophenol (625 mg,
5.0 mmol) in acetonitrile (10 mL), DBU (836 mg,
5.5 mmol) was added and the mixture was allowed to stir
at RT. for 2 h. The acetonitrile was evaporated off, the
residue was dissolved in EtOAc (20 mL), the organic
phase was washed with water (10 mL), and the organic
phase was separated, dried (MgSO4), ﬁltered, and
evaporated. The residue was subjected to ﬂash column
chromatography to yield compound 8 as white crystals,
1.18 g (75%), mp 70–72°C; Rf: 0.69 (CHCl3/Et2O, 2:1);
IR: 2973, 2929, 1762, 1603 cm1; 1H NMR (500 MHz,
CDCl3): δ 1.30 (s, 6H), 1.32 (s, 6H), 2.13 (s, 3H), 7.15–
7.21 (m, 3H), 7.32–7.35 (m, 1H), 8.22 (s, 1H); 13C NMR
(125 MHz, CDCl3): δ 19.0, 22.3, 23.0, 27.1, 27.6, 69.9,
71.9, 115.2, 118.1, 129.2, 131.5, 138.4, 139.4, 148.7,
150.3, 157.5, 170.7; MS (70 eV): m/z 316 (M+, 4), 301
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(10), 259 (63), 227 (100), 211 (42), 43 (24). Anal. Calcd.
for C17H20N2O2S: C, 64.53; H, 6.37; N, 8.85; S, 10.13.
Found: C, 64.32; H, 6.45; N, 9.01; S, 10.07.
1,1,3,3-Tetramethyl-2,3-dihydro-1H-pyrrolo-[3,4-b]benzo
[1,5]thiazepin-2-yloxyl radical (9). To a solution of
compound 8 (948 mg, 3.0 mmol) in MeOH (10 mL),
freshly made NaOMe (5 mL MeOH +7.5 mg Na) was
added. After standing at RT for 30 min, the solvent was
evaporated off, and the residue was dissolved in saturated
aq NH4Cl solution (10 mL) and extracted with CHCl3
(2 × 10 mL). The combined organic phase was dried
(MgSO4), activated MnO2 (65 mg, 0.75 mmol) was
added to the mixture, and O2 was bubbled through for
10 min. The mixture was ﬁltered, evaporated, and
puriﬁed by ﬂash column chromatography (hexane/Et2O)
to give the product as yellow crystals, 417 mg (51%), mp
104–106°C; Rf: 0.45 (hexane/EtOAc, 2:1); IR: 2971,
2926, 2856, 1618, 1596, 1576 cm1; MS (70 eV): m/z
273 (M+, 38), 259 (20), 243 (74), 136 (51), 108 (100).
Anal. Calcd. for C15H17N2OS: C, 65.90; H, 6.27; N,
10.25; S, 11.73. Found: C, 65.96; H, 6.00; N, 10.06; S,
11.64.
1,1,3,3-Tetramethyl-9,10-dihydro-1H-pyrrolo-[3,4-b]benzo
[1,5]thiazepin-2(3H)-yloxyl radical (10). To a stirred
solution of compound 9 (546 mg, 2.0 mmol) in EtOH
(15 mL), NaBH4 (76 mg, 2.0 mmol) was added at 0°C.
After removing the cooling bath, the mixture was stirred
for 2 h. The EtOH was evaporated off, and the residue
was partitioned between saturated aq NH4Cl solution
(10 mL) and CHCl3 (15 mL). The phases were separated,
the aq phase was re-extracted with CHCl3 (15 mL), and
the combined phases were dried (MgSO4), ﬁltered, and
evaporated. The residue was puriﬁed by ﬂash column
chromatography (hexane/EtOAc and CHCl3/Et2O) to
offer compound 10 as a yellow solid, 374 mg (68%),
mp 138–139°C; Rf: 0.49 (CHCl3/Et2O, 2:1); IR: 3250,
2974, 2928, 2864, 1653, 1585 cm1. For NMR study,
the paramagnetic compound 10 was reduced to the
diamagnetic secondary amine with Fe/AcOH as
published earlier [26]. 1H NMR (500 MHz, CDCl3): δ
1.206 (s, 6H), 1.34 (s, 6H), 3.79 (s, 2H), 6.93 (d, 1H,
J = 7.5 Hz), 6.98 (t, 1H, J = 7.5 Hz), 7.19 (t, 1H,
J = 7.5 Hz), 7.38 (d, 1H, J = 7.5 Hz); 13C NMR
(125 MHz, CDCl3): δ 29.1 (2C), 29.4 (2C), 46.4, 65.7,
66.9, 123.0, 123.3, 128.7, 129.3, 130.8, 132.7, 138.1,
150.4; MS (70 eV): m/z 275 (M+, 31), 245 (100), 230
(39), 136 (64). Anal. Calcd. for C15H19N2OS: C, 65.42;
H, 6.95; N, 10.17; S, 11.64. Found: C, 65.49; H, 6.76;
N, 10.06; S, 11.52.
1,1,3,3,9-Pentamethyl-9,10-dihydro-1H-pyrrolo-[3,4-b]
benzo[1,5]thiazepin-2(3H)-yloxyl radical (11). To a stirred
mixture of compound 10 (275 mg, 1.0 mmol) and
powdered K2CO3 (138 mg, 1.0 mmol) in acetonitrile
(7 mL), CH3I (426 mg, 3.0 mmol) was added and the
mixture was stirred and reﬂuxed. After 5 h, further CH3I
(142 mg, 1.0 mmol) was added, and after the
consumption of the starting material (~10 h), the solution
was diluted with CHCl3 (10 mL), the reaction mixture
was ﬁltered through sintered glass funnel, and the
solvents were evaporated off. The residue was dissolved
in EtOAc (15 mL) and washed with water (10 mL), and
the organic phase was separated, dried (MgSO4), ﬁltered,
and evaporated. The crude product was subjected to
column chromatography (hexane/EtOAc, then CHCl3/
Et2O) to give compound 11 as yellow crystals, 225 mg
(78%), mp 122–124°C; Rf: 0.76 (CHCl3/Et2O, 2:1); IR:
3055, 2977, 2930, 2816, 2788, 1653, 1579 cm1; 1H
NMR (500 MHz, CDCl3 + (PhNH)2): δ 1.20 (s, 6H), 1.36
(s, 6H), 3.0 (s, 3H), 3.5 (s, 2H,); 13C NMR (125 MHz,
CDCl3 + (PhNH)2): δ 24.0 (2C), 24.4 (2C), 44.54, 55.1,
69.8, 71.0, 120.2, 123.6, 129.2, 131.3, 134.9, 148.9,
152.7, 153.9; MS (70 eV): m/z 289 (M+, 16), 295 (30),
244 (10), 151 (100). Anal. Calcd. for C16H21N2OS: C,
66.40; H, 7.31; N, 9.68; S, 11.08. Found: C, 66.70; H,
7.19; N, 9.68; S 10.95.
2-Oxyl-1,1,3,3,9-pentamethyl-9,10-dihydro-1H-pyrrolo-
[3,4-b]benzo[1,5]thiazepin-4,4-dioxide radical (12). To a
stirred solution of compound 11 (289 mg, 1.0 mmol) and
Na2WO4 2H2O Q3(33 mg, 0.1 mmol) in MeOH (10 mL)
and water (3 mL) aq 30%, H2O2 (1 mL) was added at
0°C, and the mixture was allowed to stay at RT. After
24 h, further 30% H2O2 (0.5 mL) was added, and the
mixture was allowed to stay for further 24 h when TLC
monitoring showed the consumption of the starting
materials and sulfoxide intermediates. The mixture was
diluted with brine, extracted with CHCl3 (2 × 20 mL),
and the organic phase was dried (MgSO4), ﬁltered, and
evaporated. The residue was puriﬁed by ﬂash column
chromatography to furnish compound 12 as a yellow
solid, 176 mg (55%), mp 162–164°C; Rf: 0.48 (CHCl3/
Et2O, 2:1); IR: 2976, 2929, 1590, 1572, 1294,
1132 cm1; 1H NMR (500 MHz, CDCl3 + (PhNH)2): δ
1.26 (s, 6H), 1.63 (s, 6H), 3.04 (s, 3H), 3.77 (s, 2H); 13C
NMR (125 MHz, CDCl3 + (PhNH)2): δ 24.0 (2C), 24.8
(2C), 43.5, 55.1, 69.8, 70.8, 119.8, 123.2, 127.1, 134.7,
137.0, 139.9, 148.9, 149.9; MS (70 eV): m/z 321 (M+,
41), 291 (2), 227 (30), 212 (100). Anal. Calcd. for
C16H21N2O3S: C, 59.79; H, 6.59; N, 8.72; S, 9.98.
Found: C, 59.66; H, 6.51; N, 8.68; S, 9.87.
3-((2-Aminophenyl)thio)-4-cyano-2,2,5,5-tetramethyl-2,5-
dihydro-1H-pyrrol-1-yl acetate (13). To a stirred solution
of compound 6 (1.43 g, 5.0 mmol) and DBU (836 mg,
5.5 mmol) in acetonitrile (10 mL), 2-aminothiophenol
(625 mg, 5.0 mmol) was added and the mixture was
stirred at ambient temperature till the consumption of
starting materials (~2 h, monitored by TLC). The
acetonitrile was evaporated off, the residue was dissolved
in EtOAc (20 mL) and washed with water (10 mL), and
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the organic phase was separated, dried (MgSO4), ﬁltered,
and evaporated. The residue was puriﬁed by ﬂash column
chromatography (hexane/EtOAc) to offer compound 13
as beige crystals, 1.18 g (75%), mp 122–124°C; Rf:
0.33 (hexane/EtOAc, 2:1); IR: 3452, 3356, 2982,
2931, 2210, 1761, 1629, 1589 cm1; 1H NMR
(500 MHz, CDCl3 + (PhNH)2): δ 1.34 (s, 6H), 1.45
(s, 6H), 2.16 (s, 3H), 4.29 (s, 2H), 6.79 (m, 2H), 7.32
(m, 1H), 7.43 (m, 1H); 13C NMR (125 MHz, CDCl3):
δ 19.0, 22.6 (2C), 23.1 (2C), 27.9, 71.2, 73.5, 108.5,
112.4, 115.5, 118.8, 132.8, 137.8, 149.8, 155.5, 170.3;
MS (70 eV): m/z 331 (M+, 12), 316 (19), 289 (24),
274 (100), 215 (42), 142 (94). Anal. Calcd. for
C17H21N3O2S: C, 61.61; H, 6.39; N, 12.68; S, 9.67.
Found: C, 61.78; H, 6.35; N, 12.94; S, 9.61.
10-Amino-1,1,3,3-tetramethyl-2,3-dihydro-1H-pyrrolo-[3,4-
b]benzo[1,5]-thiazepin-2-yloxyl radical (14). A solution of
compound 13 (662 mg, 2.0 mmol) in EtOH saturated
with HCl gas was heated at reﬂux temperature for 10 h.
After cooling, the solvent was evaporated off, the residue
was dissolved in saturated aq NaHCO3 solution (50 mL)
(caution, intense foaming!), and this solution was
extracted with CHCl3 (2 × 15 mL). The combined
organic phases were dried (MgSO4), activated MnO2
(43 mg, 0.5 mmol) was added, and O2 was bubbled
through for 15 min. After ﬁltering the mixture, the
solvent was evaporated off, and the residue was subjected
to ﬂash column chromatography (CHCl3/Et2O) to give
the product as a pale yellow solid, 190 mg (30%), mp
155–157°C; Rf: 0.33 (CHCl3/MeOH, 9:1); IR: 3319,
2970, 2924, 2853, 2223, 1653 cm1; 1H NMR
(500 MHz, CDCl3 + C6F5N2H3): δ 1.21 (s, 3H), 1.25 (s,
6H), 1.34 (s, 3H), 6.24 (s, 2H), 7.04–7.28 (m, 4H); 13C
NMR (125 MHz, CDCl3 + C6F5N2H3): δ 23.3, 23.7,
27.0, 27.8, 69.0, 70.9, 124.4, 125.2, 128.2, 128.9, 131.8,
137.4, 147.0, 149.0, 158.0; MS (70 eV): m/z 288 (M+,
10), 258 (100), 226 (62), 215 (62). Anal. Calcd. for
C15H18N3OS: C, 62.47; H, 6.29; N, 14.57; S, 11.12.
Found: C, 62.42; H, 6.35; N, 14.71; S, 11.06.
11-Hydroxy-1,1,3,3-tetramethyl-1,2,3,11-tetrahydrobenzimidazo
Q4 [2,1-b]pyrrolo[3,4-e][1,3-]thiazin-2-yloxyl radical (15). To a
stirred suspension of 2-mercaptobenzimidazole (300 mg,
2.0 mmol) and DBU (638 mg, 4.2 mmol) in acetonitrile
(10 mL), compound 1 (494 mg, 2.0 mmol) was added
and the mixture was heated at reﬂux temperature for
30 min, upon which the solid dissolved. After cooling,
the acetonitrile was evaporated off, the residue was
dissolved in CHCl3 (30 mL) and washed with brine
(10 mL), and the organic phase was separated, dried
(MgSO4), ﬁltered, and evaporated. The residue was
puriﬁed by ﬂash column chromatography (hexane/
EtOAc, CHCl3/Et2O) to give the title compound as a
yellow solid, 474 mg (75%), mp 219–221°C; Rf: 0.30
(CHCl3/Et2O, 2:1); IR: 2983, 2924, 2854, 1617 cm
1;
1H NMR (500 MHz, CD3OD + C6F5N2H3): δ 1.36 (s,
3H), 1.39 (s, 3H), 1.40 (s, 3H), 1.49 (s, 3H), 6.58 (s,
1H), 7.31 (m, 2H), 7.57 (m, 1H), 7.70 (m, 1H); 13C
NMR (125 MHz, CDCl3): δ 23.1, 23.4, 24.0, 24.4,
69.0, 69.7, 73.1, 110.7, 117.0, 122.2, 123.1, 133.5,
142.4, 144.7, 149.7, 152.5; MS (70 eV): m/z 316 (M+,
20), 286 (239), 282 (100), 269 (83), 150 (59). Anal.
Calcd. for C16H18N3O2S: C, 60.74; H, 5.73; N, 13.28;
S, 10.13. Found: C, 60.58; H, 5.91; N, 13.41; S, 10.01.
DECLARATION OF INTEREST
The authors declare no conﬂict of interest.
Acknowledgments. The project was supported by National,
Research, Development and Innovation Ofﬁce (OTKA104956).
The present scientiﬁc contribution is dedicated to the 650th
anniversary of the foundation of the University of Pécs,
Hungary.
REFERENCES AND NOTES
[1] Altenbach, C.; López, C. J.; Hideg, K.; Hubbell, W. L.
Methods Enzymol 2015, 564, 59.
[2] Lambert, K. M.; Bobbitt, J. M.; Eldirany, S. A.; Kissane, L. E.;
Sheridan, R. K.; Stempel, Z. D.; Sternberg, H. F.; Bailey, F. W. Chem A
Eur J 2016, 22, 5156.
[3] Winter, S. M.; Hill, S.; Oakley, R. T. J Am Chem Soc 2015,
137, 3720.
[4] (a) Zakrzewski, J.; Huras, B. Beilstein J Org Chem 2015, 11,
1155. (b) Gophane, B. D.; Sigurdsson, T. S. Beilstein J Org Chem
2015, 11, 219. (c) Kálai, T.; Kulcsár, G.; Jekő, J.; Ősz, E.; Sümegi, B.;
Hideg, K. ARKIVOC 2004, vii, 266.
[5] Sennik, E.; Sennik, B.; Alev, O.; Kilinc, N.; Yilmaz, F.;
Ozturk, Z. Z. J Appl Polym Sci 2016, 33, 43641.
[6] (a) Rosantzev, E. G.; Neiman, M. B. Tetrahedron 1964, 20,
131. (b) Rozantsev, E. G. Free Nitroxyl Radicals; Plenum Press: New
York, 1970.
[7] Kálai, T.; Balog, M.; Jekő, J.; Hideg, K. Synthesis 1998 1476.
[8] Kálai, T.; Bagi, N.; Jekő, J.; Berente, Z.; Hideg, K. Synthesis
2010 1702.
[9] Kálai, T.; Jekő, J.; Hideg, K. Synthesis 2000 831.
[10] Bognár, B.; Kálai, T.; Gulyás-Fekete, G.; Lazsányi, N.; Hideg,
K. Synthesis 2015 985.
[11] Kálai, T.; Jekő, J.; Berente, Z.; Hideg, K. Synthesis 2006
439.
[12] Kulcsár, G.; Kálai, T.; Jekő, J.; Hideg, K. Synthesis 2003
1361. Chem Abs , 1971(75), 49044.
[13] Kálai, T.; Bognár, B.; Zsolnai, D.; Berente, Z.; Hideg, K. Syn-
thesis 2012 3655.
[14] Hankovszky, H. O.; Hideg, K. Acta Chim Acad Sci Hung
1971, 68, 403.
[15] Lévai, A.; Kiss-Szikszay, A. ARKIVOC 2008, i, 65.
[16] El-Bayouki, K. A. M. J Sulfur Chem 2011, 32, 623.
[17] Warawa, E. J.; Migler, B. M. US patent 4879288 Chem. Abstr.
1988, 108, 37876.
[18] Schmutz, J.; Hunziker, F. US patent 3539573Chem Abstr
2010, 152, 75087.
[19] Youcheng, L.; Zhongli, G.; Tongbao, K. 1988, 33, 2032.Chem
Abstr 1989, 111, 233624.
6 B. Bognár, B. Varga, T. Kálai, V. Csokona, G. G. Fekete, C. Sár, and K. Hideg Vol 000
Journal of Heterocyclic Chemistry DOI 10.1002/jhet
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
[20] Hideg, K.; Sár, P. C.; Hankovszky, H. O.; Tamás, T.;
Jerkovich, G. Synthesis 1993, 390.
[21] Demina, M. M.; Novopashin, P. S.; Kon’kova, T. V.; Afonin,
A. V.; Sarapulova, G. I.; Afonin, A. V.; Medvedeva, A. S. Chemistry of
Heterocyclic Compounds 2006, 42, 1457.
[22] Naeimi, H.; Heidarnezhad, A. Synth Commun 2016, 46, 594.
[23] (a) Torrini, I.; Giampiero, P. Z.; Paglialunga Paradisi, M.
Heterocycles 1988, 27, 401. (b) Matsudo, K.; Sunago, M.; Okutani, N.;
Takagi, T.; Nakamoto, H.; Kobayashi, M. Chem Pharm Bull 1995,
43, 1643.
[24] Cziráky, Z.; Kóródi, F. Heterocycles 1993, 36, 2475.
[25] Zhdanov, R. I. Bioactive Spin Labels; Berlin: Springer,
1992.
[26] Sár, P. C.; Kálai, T.; Bárácz, M. N.; Jerkovich, G.; Hideg, K.
Synthetic Commun 1995, 25, 2929.
Month 2017 Reaction of pyrroline nitroxides with N- and S-Binucleophiles 7
Journal of Heterocyclic Chemistry DOI 10.1002/jhet
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
Author Query Form
Journal: Journal of Heterocyclic Chemistry
Article: jhet_2850
Dear Author,
During the copyediting of your paper, the following queries arose. Please respond to these by annotating your proofs with
the necessary changes/additions.
• If you intend to annotate your proof electronically, please refer to the E-annotation guidelines.
• If you intend to annotate your proof by means of hard-copy mark-up, please use the standard prooﬁng marks. If manually
writing corrections on your proof and returning it by fax, do not write too close to the edge of the paper. Please remember
that illegible mark-ups may delay publication.
Whether you opt for hard-copy or electronic annotation of your proofs, we recommend that you provide additional clari-
ﬁcation of answers to queries by entering your answers on the query sheet, in addition to the text mark-up.
Query No. Query Remark
Q1 AUTHOR: Please give manufacturer information for all products: company name,
town, state (two-letter abbreviation, if USA), and country.
Q2 AUTHOR: “pentaﬂuorophenyhydrazine” has been changed to “pentaﬂuorophenyl
hydrazine.” Please check.
Q3 AUTHOR: Please conﬁrm that 2H2O is correct.
Q4 AUTHOR: Please conﬁrm that this heading is correct.
Q5 AUTHOR: Please conﬁrm that given names (red) and surnames/family names
(green) have been identiﬁed correctly.
 
USING e-ANNOTATION TOOLS FOR ELECTRONIC PROOF CORRECTION  
 
Required software to e-Annotate PDFs: Adobe Acrobat Professional or Adobe Reader (version 7.0 or 
above). (Note that this document uses screenshots from Adobe Reader X) 
The latest version of Acrobat Reader can be downloaded for free at: http://get.adobe.com/uk/reader/ 
 
Once you have Acrobat Reader open on your computer, click on the Comment tab at the right of the toolbar:  
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Replace (Ins) Tool – for replacing text. 
 
Strikes a line through text and opens up a text 
box where replacement text can be entered. 
How to use it 
 Highlight a word or sentence. 
 Click on the Replace (Ins) icon in the Annotations 
section. 
 Type the replacement text into the blue box that 
appears. 
This will open up a panel down the right side of the document. The majority of 
tools you will use for annotating your proof will be in the Annotations section, 
pictured opposite. We’ve picked out some of these tools below: 
2. Strikethrough (Del) Tool – for deleting text. 
 
Strikes a red line through text that is to be 
deleted. 
How to use it 
 Highlight a word or sentence. 
 Click on the Strikethrough (Del) icon in the 
Annotations section. 
 
 
3. Add note to text Tool – for highlighting a section 
to be changed to bold or italic. 
 
Highlights text in yellow and opens up a text 
box where comments can be entered. 
How to use it 
 Highlight the relevant section of text. 
 Click on the Add note to text icon in the 
Annotations section. 
 Type instruction on what should be changed 
regarding the text into the yellow box that 
appears. 
4. Add sticky note Tool – for making notes at 
specific points in the text. 
 
Marks a point in the proof where a comment 
needs to be highlighted. 
How to use it 
 Click on the Add sticky note icon in the 
Annotations section. 
 Click at the point in the proof where the comment 
should be inserted. 
 Type the comment into the yellow box that 
appears. 
 
USING e-ANNOTATION TOOLS FOR ELECTRONIC PROOF CORRECTION  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For further information on how to annotate proofs, click on the Help menu to reveal a list of further options: 
5. Attach File Tool – for inserting large amounts of 
text or replacement figures. 
 
Inserts an icon linking to the attached file in the 
appropriate pace in the text. 
How to use it 
 Click on the Attach File icon in the Annotations 
section. 
 Click on the proof to where you’d like the attached 
file to be linked. 
 Select the file to be attached from your computer 
or network. 
 Select the colour and type of icon that will appear 
in the proof. Click OK. 
6. Add stamp Tool – for approving a proof if no 
corrections are required. 
 
Inserts a selected stamp onto an appropriate 
place in the proof. 
How to use it 
 Click on the Add stamp icon in the Annotations 
section. 
 Select the stamp you want to use. (The Approved 
stamp is usually available directly in the menu that 
appears). 
 Click on the proof where you’d like the stamp to 
appear. (Where a proof is to be approved as it is, 
this would normally be on the first page). 
7. Drawing Markups Tools – for drawing shapes, lines and freeform 
annotations on proofs and commenting on these marks. 
Allows shapes, lines and freeform annotations to be drawn on proofs and for 
comment to be made on these marks.. 
How to use it 
 Click on one of the shapes in the Drawing 
Markups section. 
 Click on the proof at the relevant point and 
draw the selected shape with the cursor. 
 To add a comment to the drawn shape, 
move the cursor over the shape until an 
arrowhead appears. 
 Double click on the shape and type any 
text in the red box that appears. 
